← Eichor
Study identifier: NCT05935683 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Rhinosinusitis Italian Network: the Italian Registry for Severe, Uncontrolled Chronic Rhinosinusitis

Condition: Chronic Rhinosinusitis  ·  Sponsor: Italian Academy of Rhinology

PhaseN/A
Planned participants5000
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This observatory aims to collect, as widely as possible, the Italian cases of patients with uncontrolled CRS. Patient will be enrolled by the centers of the Italian Network of Rhinosinusitis (Rhinosinusitis Italian Network: RINET), and they will be treated using a multidisciplinary team approach (allergists, otolaryngologists and pneumologists) in a real-world clinical set-up. This real-life chronic rhinosinusitis registry aims at longitudinal data collection from patients attending specialist care centres across Italy.

This description comes directly from the study's public registry record.

Talk to the study team

Enrico Marco Heffler, MD, PhD  ·  02 82241  ·  enrico.heffler@hunimed.eu

Concetta Sirena, Dr.  ·  342 0790871  ·  concetta.sirena@infomed-online.it

Always discuss trial participation with your own doctor first.

Locations (1)

Personalized Medicine, Asthma and Allergy - IRCCS Humanitas Research HospitalRozzano, MIlan, ItalyRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05935683